Final results of the HIV prevention study VOICE published

February 5, 2015 1:14 AM

17 0

Researchers who conducted VOICE, a major HIV prevention trial involving more than 5,000 women in Africa, describe the study's primary results in this week's issue of the New England Journal of Medicine (NEJM), outlining in detail how the three products tested were safe but overall not effective in preventing HIV.

The study also reports the degree to which women did not use the products daily as instructed, with tests of blood indicating that just three months into the trial a majority of study participants were not using their assigned product - either an antiretroviral (ARV) tablet (tenofovir or Truvada) or...

Read more

To category page